Products
Online Inquiry
Ticlopidine hydrochloride
Cat. No.:
0225LY-0647
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Ticlopidine hydrochloride is a potent inhibitor of platelet aggregation that is frequently employed during the surgical placement of coronary artery stents.
Synonym:
Ticlodone; Ticlopidine HCl; Ticlodix; 53885-35-1; Ticlid; Tiklid; 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride; Ipaton; Ticlopidine (hydrochloride); 5-[(2-chlorophenyl)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridine hydrochloride; Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro-, hydrochloride; 5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno-(3,2-c)pyridine hydrochloride; 5-(2-chloro-benzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride; 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridinehydrochloride
CAS No.:
53885-35-1
Compound CID:
65335
Formula:
C14H15Cl2NS
Formula Weight:
300.25
Specification
Targets&IC50:
P2 receptor: 2 μM
Relative Density:
1.37 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ticlopidine hydrochloride can be used in hematology research to investigate the inhibition of ADP-induced platelet aggregation.
Library Information
Target:
Adenosine receptor
Receptor:
Adenosine receptor
Pathways:
GPCR/G protein signaling; Neuronal signaling
Plate Number:
AOCL-9
Plate Location:
d3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
65 mg/mL; 216.49 mM
Water Max Solubility:
30 mg/mL; 99.92 mM
